This is not the most recent version of the article. View current version (26 JUL 2014)

Intervention Protocol

Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis

  1. Loredana La Mantia2,
  2. Alberto Vaona1,*,
  3. Marco Rovaris3,
  4. Francesco Berardo4,
  5. Serena Frau5,
  6. Anna Gandini6,
  7. Anna Longobardi1,
  8. Giulio Rigon1,
  9. Carlo Di Pietrantonj7,
  10. Bianca Weinstock-Guttman8

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 7 SEP 2011

Assessed as up-to-date: 10 JUL 2011

DOI: 10.1002/14651858.CD009333


How to Cite

La Mantia L, Vaona A, Rovaris M, Berardo F, Frau S, Gandini A, Longobardi A, Rigon G, Di Pietrantonj C, Weinstock-Guttman B. Interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD009333. DOI: 10.1002/14651858.CD009333.

Author Information

  1. 1

    Azienda ULSS 20 Verona, Primary Care, Verona, Italy

  2. 2

    I.R.C.C.S. Santa Maria Nascente Fondazione Don Gnocchi, Unit of Neurology - Multiple Sclerosis Center, Milano, Italy

  3. 3

    I.R.C.S.S. S. Maria Nascente - Fondazione Don Gnocchi, U.O. Sclerosi Multipla, Milano, Italy

  4. 4

    Azienda Opsedaliera di Verona - Department of Pharmacy, Unità di Valutazione dell'Efficacia del Farmaco (UVEF) - Veneto Regional Drug Information Center, Verona, Italy

  5. 5

    Dialogo sui Farmaci Srl, Drug Information, Verona, Italy

  6. 6

    Azienda ULSS 21 - Legnago, Regional Health Service, Legnago, Varese, Italy

  7. 7

    Azienda Sanitaria Locale ASL AL, Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field, Alessandria, Piemonte, Italy

  8. 8

    Jacobs Neurological Institute, SUNY University of Buffalo, Director Baird MS Center and Pediatric MS Center of Excellence, Buffalo, New York, USA

*Alberto Vaona, Primary Care, Azienda ULSS 20 Verona, Ospedale di Marzana, Piazzale Ruggero Lambranzi 1, Verona, 37142, Italy. aisamaisa@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 SEP 2011

SEARCH

This is not the most recent version of the article. View current version (26 JUL 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to assess whether IFN-beta and GA differ in terms of efficacy and safety in the treatment of patients with RRMS